story of the week
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
JAMA 2023 Oct 05;[EPub Ahead of Print], M Sodhi, R Rezaeianzadeh, A Kezouh, M EtminanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.